SensiGen
Ann Arbor, Michigan, United States
About SensiGen
SensiGen is a biotechnology company focused on gene-based molecular diagnostics. Their mission is to develop and commercialize nucleic acid tests that detect serious diseases earlier, monitor diseases more effectively, and lower overall healthcare costs. The Company has a late stage pipeline of high value diagnostic tests for cervical cancer, head & neck cancer, chronic kidney disease and lupus, all of which address very large markets with significant unmet needs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $250.0K
- Funding stage: M&A
- Last round: Debt Financing (May 2007)
- Website: sensigen.com
- Phone: 734-213-7600
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Canonical: https://fsome.com/organization/sensigen-2476715 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.